Ketro RX Pain Gel vs Voltaren (Diclofenac) — What's the Difference?
Ketro RX Pain Gel uses prescription-strength ketorolac, which has 5x the analgesic potency of diclofenac (Voltaren's active ingredient). Both are topical NSAIDs, but Ketro RX is prescription-strength and compounded per patient, while Voltaren is an OTC product at fixed 1% concentration.
Voltaren (diclofenac 1% gel) became the first OTC topical NSAID in the US in 2020 and quickly became the best-selling topical pain product in America. But OTC means fixed strength, limited potency, and a one-size-fits-all formulation. For people whose pain needs more than what you can buy off the shelf, prescription-strength ketorolac offers a fundamentally different level of anti-inflammatory power.
This page compares the two products head-to-head: active ingredients, potency, clinical evidence, cost, and when to choose which. No marketing spin — just the pharmacology.
Ketro RX vs Voltaren — Side-by-Side Comparison
| Feature | Ketro RX Pain Gel | Voltaren (Diclofenac) |
|---|---|---|
| Active Ingredient | Ketorolac (prescription NSAID) | Diclofenac sodium 1% |
| Strength | Prescription-strength, compounded per patient | Fixed OTC concentration (1%) |
| Availability | Prescription required (online consultation included) | Over-the-counter at any pharmacy |
| Analgesic Potency | 5x diclofenac (mg-for-mg) | Baseline |
| Anti-inflammatory Potency | 2x diclofenac (mg-for-mg) | Baseline |
| GI Side Effects | Equivalent to placebo (topical delivery) | Equivalent to placebo (topical delivery) |
| Application | Apply to affected area as directed by physician | Apply up to 4x daily per package directions |
| Cost | ~$135-145 (includes Rx consultation) | ~$15-25 OTC |
| Origin | Originally formulated for the Boston Red Sox | Novartis / GSK consumer health |
| Compounding | Made per patient by US pharmacy (Precision Compounding) | Mass-manufactured, fixed formula |
Understanding the Difference: Ketorolac vs Diclofenac
Both ketorolac and diclofenac are non-steroidal anti-inflammatory drugs (NSAIDs). They work through the same basic mechanism: inhibiting cyclooxygenase (COX) enzymes to reduce prostaglandin production, which decreases inflammation, pain, and swelling at the tissue level. But the similarity ends there.
Ketorolac is one of the most potent NSAIDs ever developed. On a milligram-per-milligram basis, ketorolac delivers approximately 5 times the analgesic (pain-relieving) potency and 2 times the anti-inflammatory potency of diclofenac. This is why ketorolac was originally used in hospitals and emergency departments for acute pain management — it was the NSAID physicians reached for when they needed maximum potency.
Diclofenac became the first OTC topical NSAID in the US when Voltaren Arthritis Pain was approved for over-the-counter sale in 2020. At 1% concentration, it provides effective relief for mild to moderate musculoskeletal pain. But 1% diclofenac is a fixed, standardized dose designed to be safe for unsupervised consumer use — not to maximize therapeutic potency.
Topical ketorolac takes a different approach. Because it requires a prescription and physician oversight, it can deliver higher potency anti-inflammatory medication directly through the skin. The formulation is compounded per patient, not mass-produced. And the potency differential is not incremental — it is a 5-fold increase in analgesic power.
Prescription Ketorolac vs OTC Diclofenac
Both products deliver NSAID medication through the skin. The difference is potency, formulation control, and physician oversight. Here is how prescription-strength topical ketorolac compares to OTC diclofenac 1% on the metrics that matter.
Prescription-strength NSAID with 5x analgesic potency. Compounded per patient by a US pharmacy under physician supervision.
- 5x analgesic potency vs diclofenac
- 2x anti-inflammatory potency vs diclofenac
- Compounded per patient (not mass-produced)
- Physician-supervised dosing
- Originally formulated for professional athletes
- GI side effects equivalent to placebo
OTC topical NSAID at fixed 1% concentration. Available at any pharmacy without a prescription.
- Fixed 1% concentration (no customization)
- Baseline NSAID potency
- Mass-manufactured formula
- No physician oversight required
- Available at any pharmacy or drugstore
- GI side effects equivalent to placebo
Clinical Evidence: Topical NSAIDs and Ketorolac
Published, peer-reviewed data on topical NSAID efficacy, ketorolac potency, and the safety profile of topical vs oral delivery. No marketing claims — just the research.
Cochrane systematic review (N=1,735): topical NSAIDs achieved 55% clinical success vs 54% for oral. Statistically equivalent efficacy.
Topical NSAIDs produce 5-17x lower peak serum concentrations than oral equivalents. Medication stays where you apply it.
Meta-analysis confirmed topical NSAIDs show GI toxicity equivalent to placebo. No stomach, kidney, or cardiovascular burden.
Pharmacological comparison databases consistently rank ketorolac as approximately 5 times more potent than diclofenac for analgesia and approximately 2 times more potent for anti-inflammatory effect on a milligram-per-milligram basis. This potency is why ketorolac was originally developed for hospital-level acute pain and why it remains prescription-only.
A double-blind, placebo-controlled study evaluated topical ketorolac gel for acute ankle sprains. Patients receiving topical ketorolac showed significantly greater pain reduction and functional improvement compared to placebo, with minimal systemic absorption and no serious adverse events reported.
The Cochrane Collaboration's systematic review of topical NSAIDs for acute musculoskeletal pain analyzed 61 studies with over 8,000 participants. Topical diclofenac achieved a number needed to treat (NNT) of 1.8 for at least 50% pain reduction — meaning fewer than 2 patients need treatment for 1 to achieve significant relief. Topical NSAIDs as a class were effective with low systemic side effect profiles.
A 2024 meta-analysis published in PMC compared topical vs oral NSAIDs across multiple pain conditions. Topical NSAIDs demonstrated equivalent efficacy to oral for superficial musculoskeletal conditions while producing significantly fewer systemic adverse events. Topical delivery resulted in 2-8% of the peak serum concentration of oral administration — confirming the localized action mechanism.
Clinical outcomes data from Precision Compounding Pharmacy showed patients using topical ketorolac gel achieved an average 55.8% reduction in pain scores within 15 days of consistent use. Patients reported significant improvement in both pain intensity and functional capacity without the gastrointestinal complications typical of oral NSAID therapy.
When to Choose Voltaren vs Ketro RX
Not every pain needs a prescription. Here is an honest framework for when OTC diclofenac may be sufficient and when prescription ketorolac makes a meaningful difference.
OTC diclofenac 1% is an effective topical NSAID for mild to moderate pain that responds to standard anti-inflammatory treatment.
- Mild, occasional muscle soreness after exercise
- Minor strains and sprains during recovery
- Mild joint stiffness with low inflammation
- Intermittent pain that resolves within a few days
- Preference for no-prescription, immediate access
- Budget is a primary consideration
Prescription-strength ketorolac delivers meaningfully higher potency for pain that needs more than what OTC provides.
- Moderate-to-severe pain not adequately controlled by OTC
- Chronic inflammatory conditions (arthritis, TMJ, tendinitis)
- Deep-tissue inflammation requiring higher potency
- Pain that keeps coming back despite OTC treatment
- Patients who want to avoid oral NSAIDs entirely
- Post-surgical recovery requiring stronger intervention
- Professional athletes and high-performance demands
Prescription Strength + Daily Maintenance
Prescription-strength anti-inflammatory for pain and flares. Daily topical magnesium for ongoing muscle tension and recovery. Both applied directly where you need them — not through your whole body first.
Prescription-strength topical ketorolac — 5x the analgesic potency of diclofenac (Voltaren). Originally formulated for the Boston Red Sox. Compounded per patient by Precision Compounding Pharmacy (US). Applied directly to the pain site with minimal systemic absorption. Online consultation included.
- Ketorolac: 5x analgesic potency of diclofenac
- 55.8% pain reduction by day 15 in clinical data
- GI side effects equivalent to placebo
- Compounded per order by US pharmacy
- Online physician consultation included
Skincare-formulated topical magnesium for daily muscle tension, soreness, and recovery. Magnesium plays a direct role in muscle relaxation and contraction. Fast-absorbing, non-greasy, no sting — formulated like premium skincare, not drugstore. No prescription needed.
- Premium transdermal magnesium delivery
- Supports muscle relaxation and recovery
- Fast-absorbing, non-greasy formula
- Formulated like skincare, not drugstore
- No prescription needed
Ketro RX vs Voltaren FAQ
Sources and Citations
- Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database of Systematic Reviews. 2015;(6):CD007402. PMC6426435
- Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews. 2016;(4):CD007400. doi:10.1002/14651858.CD007400.pub4
- Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. Journal of Clinical Pharmacology. 2010;50(1):50-61. doi:10.1002/jcph.806
- Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis. Drugs & Aging. 2019;36(Suppl 1):7-19. doi:10.1007/s40266-019-00716-4
- Diclofenac vs Ketorolac: Clinical Comparison. Drugs.com. drugs.com/compare/diclofenac-vs-ketorolac
- Topical ketorolac tromethamine gel for pain relief in ankle sprains: a double-blind, placebo-controlled study. PubMed. PMID: 2105985. pubmed.ncbi.nlm.nih.gov/2105985
- Topical vs Oral NSAID Safety and Efficacy — Systematic Review and Meta-Analysis. PMC. 2024. PMC10980447
- Precision Compounding Pharmacy. Clinical Outcomes Report: Topical Ketorolac Gel. 2025. (Data on File)
Conditions Where Prescription Topical Makes a Difference
The masseter sits right under the skin — ideal for topical delivery. Prescription ketorolac applied directly to the jaw without systemic side effects.
ACR recommends topical NSAIDs as first-line for knee and hand OA. When OTC diclofenac isn't enough, prescription ketorolac delivers 5x the potency.
Superficial back muscles respond well to topical anti-inflammatory treatment. Prescription strength for pain that OTC products can't reach.
Desk tension, stress knots, and chronic neck pain. Topical delivery to superficial trapezius and cervical muscles.
Topical NSAIDs applied to temples, forehead, and neck muscles for headache relief without oral medication.
Post-workout inflammation and delayed onset muscle soreness. Topical anti-inflammatory recovery without pills.
Stronger Than Voltaren
Prescription-strength ketorolac. 5x the analgesic potency of diclofenac. Applied directly where you need it.
This content is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any new treatment. Individual results may vary. Ketro RX Pain Gel requires a prescription. Voltaren is a registered trademark of GSK Consumer Healthcare. Ketro is not affiliated with Voltaren or GSK. Clinical data referenced from published peer-reviewed studies.